UCI Health
UCI Health
Orange, California, United States7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Phase 3 | 2026-10-01 | NCT06200207 | |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 2 | 2026-09-25 | NCT06233461 | |
| A Study of TAK-505 in Adults With Solid Tumors | Malignant Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-09-09 | NCT07436728 | |
| Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study | Fatigue, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cancer, neoplasm | Recruiting | Not applicable | 2026-07-10 | NCT07581080 | |
| Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 4 | 2026-07-01 | NCT06057402 | |
| Vitaccess Real MG Registry | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Not stated | 2025-07-29 | NCT06064461 | |
| A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Cervical Disc Disease at 2 Contiguous Levels | nervous system disorder, neuromuscular disease, peripheral nervous system disorder, radiculopathy | Active, not recruiting | Not applicable | 2024-03-08 | NCT04564885 |